Business Description
Unionkorea Pharm Co Ltd
ISIN : KR7080720006
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.36 | |||||
Debt-to-EBITDA | -5.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.29 | |||||
Beneish M-Score | -3.84 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.9 | |||||
3-Year EBITDA Growth Rate | 8.4 | |||||
3-Year EPS without NRI Growth Rate | -6.9 | |||||
3-Year FCF Growth Rate | 53 | |||||
3-Year Book Growth Rate | -21.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 10.97 | |||||
9-Day RSI | 24.09 | |||||
14-Day RSI | 33.72 | |||||
6-1 Month Momentum % | 39.68 | |||||
12-1 Month Momentum % | 6.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 86.22 | |||||
Days Sales Outstanding | 187.59 | |||||
Days Payable | 28.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2.9 | |||||
Shareholder Yield % | 2.53 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.67 | |||||
Operating Margin % | -9.33 | |||||
Net Margin % | -29.19 | |||||
FCF Margin % | 5.31 | |||||
ROE % | -49.34 | |||||
ROA % | -17.85 | |||||
ROIC % | -7.31 | |||||
ROC (Joel Greenblatt) % | -18.78 | |||||
ROCE % | -24.15 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.61 | |||||
PB Ratio | 1.47 | |||||
Price-to-Tangible-Book | 1.52 | |||||
Price-to-Free-Cash-Flow | 11.53 | |||||
Price-to-Operating-Cash-Flow | 6.86 | |||||
EV-to-EBIT | -6.52 | |||||
EV-to-EBITDA | -9.88 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | 20.81 | |||||
Earnings Yield (Greenblatt) % | -15.34 | |||||
FCF Yield % | 8.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Unionkorea Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 65,348.098 | ||
EPS (TTM) (â‚©) | -2640 | ||
Beta | 0.78 | ||
Volatility % | 27.54 | ||
14-Day RSI | 33.72 | ||
14-Day ATR (â‚©) | 258.512361 | ||
20-Day SMA (â‚©) | 6095 | ||
12-1 Month Momentum % | 6.84 | ||
52-Week Range (â‚©) | 4210 - 6460 | ||
Shares Outstanding (Mil) | 7.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Unionkorea Pharm Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Unionkorea Pharm Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Unionkorea Pharm Co Ltd Frequently Asked Questions
What is Unionkorea Pharm Co Ltd(XKRX:080720)'s stock price today?
When is next earnings date of Unionkorea Pharm Co Ltd(XKRX:080720)?
Does Unionkorea Pharm Co Ltd(XKRX:080720) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |